ストックスクリーナーアプリを入手
1.5325
0.65%
-0.0075
前日終値:
$1.54
開ける：
$1.53
24時間の取引高:
156.20K
Relative Volume:
0.15
時価総額：
$20.42M
収益：
-
当期純損益:
$-7.51M
株価収益率:
-1.161
EPS:
-1.32
ネットキャッシュフロー:
$-8.02M
1週間 パフォーマンス:
-3.16%
1か月 パフォーマンス:
-15.93%
6か月 パフォーマンス:
+89.73%
1年 パフォーマンス:
+72.59%
1日の値動き範囲:
$1.52
$1.5683
1週間の範囲:
$1.45
$1.7197
52週間の値動き範囲:
$0.6554
$3.80
Hoth Therapeutics Inc Stock (HOTH) Company Profile
名前
Hoth Therapeutics Inc
セクター
電話
(646)756-2997
住所
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
HOTH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.54 | 20.42M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
411.31 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.76 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
581.25 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
813.11 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
163.99 | 34.11B | 398.11M | -1.03B | -868.57M | -5.7032 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-10-15 | 開始されました | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc (HOTH) 最新ニュース
Why hedge funds are buying Hoth Therapeutics Inc. stockLong Setup & Weekly Market Pulse Alerts - newser.com
Measuring Hoth Therapeutics Inc.’s beta against major indicesMarket Movement Recap & Daily Profit Focused Stock Screening - newser.com
Should you wait for a breakout in Hoth Therapeutics Inc.Jobs Report & Daily Entry Point Trade Alerts - newser.com
How to forecast Hoth Therapeutics Inc. trends using time seriesTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Can momentum traders help lift Hoth Therapeutics Inc.Quarterly Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Chart based analysis of Hoth Therapeutics Inc. trendsEntry Point & Smart Investment Allocation Insights - newser.com
Will Hoth Therapeutics Inc. stock maintain growth storyStop Loss & Free Weekly Watchlist of Top Performers - newser.com
What candlestick patterns are forming on Hoth Therapeutics Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Is Hoth Therapeutics Inc. stock entering bullish territoryJuly 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
What valuation multiples suggest for Hoth Therapeutics Inc. stockMarket Movers & Fast Entry Momentum Trade Alerts - newser.com
What analysts say about Hoth Therapeutics Inc stockSector ETF Performance & Free High Yield Growth Strategies - earlytimes.in
Hoth Therapeutics expands AI capabilities with NVIDIA partnership By Investing.com - Investing.com South Africa
Hoth Therapeutics shares climb after expanding AI partnership with NVIDIA - MSN
Hoth Therapeutics stock rises after expanding AI initiative with NVIDIA By Investing.com - Investing.com Nigeria
Hoth Therapeutics stock rises after expanding AI initiative with NVIDIA - Investing.com
Hoth Therapeutics rises as it expands AI push with Nvidia licenses - TradingView
Hoth Therapeutics expands artificial intelligence initiative, selects NVIDIA AI Enterprise platform - MarketScreener
Hoth Therapeutics expands AI capabilities with NVIDIA partnership - Investing.com
Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform - MarketScreener
Hoth Therapeutics CEO Robb Knie to Present at BIO-Europe in Vienna, Austria November 3-5, 2025 - WV News
Analyzing Hoth Therapeutics Inc. with multi timeframe chartsVolume Spike & Community Verified Swing Trade Signals - newser.com
Best data tools to analyze Hoth Therapeutics Inc. stock2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Hoth Therapeutics Announces Pipeline Presentation at the 2022 BIO International Convention - ADVFN
EGFR Inhibitors Induced Skin Disorders Market Research 2025-2035: Epidemiology, Regulations, Pipeline Analysis Featuring Azitra, Hoth Therapeutics, and Lutris PharmaResearchAndMarkets.com - The AI Journal
About Us - FinancialContent
Is Hoth Therapeutics Inc a good long term investmentCandlestick Pattern Analysis & Free Exceptional Risk Adjusted Gains - earlytimes.in
What institutional flow reveals about Hoth Therapeutics Inc.Portfolio Value Summary & High Yield Stock Recommendations - newser.com
EGFR Inhibitors-Induced Skin Disorders Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lutris Pharma, Hoth Therapeutics, TWi Biotechnology - Barchart.com
Hoth expands HT-001 development with patents for cancer therapy side effects - Investing.com Nigeria
Hoth expands HT-001 development with patents for cancer therapy side effects By Investing.com - Investing.com South Africa
Hoth Therapeutics Expands Patent Portfolio for HT-001 to Target Wider Range of Skin Toxicities - MarketScreener
Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities - WV News
Hoth Therapeutics Inc (HOTH) 財務データ
収益
当期純利益
現金流量
EPS
4.90%
1.21%
大文字化:
|
ボリューム (24 時間):